SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021052
Filing Date
2018-08-09
Accepted
2018-08-09 16:11:57
Documents
57
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kzr-10q_20180630.htm 10-Q 1740735
2 EX-31.1 kzr-ex311_9.htm EX-31.1 18142
3 EX-31.2 kzr-ex312_8.htm EX-31.2 18286
4 EX-32.1 kzr-ex321_7.htm EX-32.1 9205
  Complete submission text file 0001564590-18-021052.txt   5975229

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT kzr-20180630.xml EX-101.INS 1330345
6 XBRL TAXONOMY EXTENSION SCHEMA kzr-20180630.xsd EX-101.SCH 41595
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kzr-20180630_cal.xml EX-101.CAL 35706
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kzr-20180630_def.xml EX-101.DEF 122214
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kzr-20180630_lab.xml EX-101.LAB 314896
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kzr-20180630_pre.xml EX-101.PRE 243942
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38542 | Film No.: 181005150
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences